NasdaqGS - Delayed Quote • USD
Ovid Therapeutics Inc. (OVID)
At close: April 24 at 4:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BERNSTEIN KAREN Director | Purchase | Feb 26, 2019 | 20,000 |
| DURING MATTHEW M.D. President | Conversion of Exercise of derivative security | May 10, 2017 | 4,679,410 |
| LEVIN JEREMY M Chief Executive Officer | Purchase | Mar 18, 2024 | 3,652,180 |
| PERONE THOMAS MICHAEL General Counsel | Stock Award(Grant) | Feb 22, 2024 | 28,125 |
| RAKHIT AMIT M.D. President | Sale | Jul 14, 2021 | 726,823 |
| RONA JEFFREY A Chief Financial Officer | Stock Award(Grant) | Feb 22, 2024 | 28,125 |
| TAKEDA PHARMACEUTICAL CO., LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 8, 2019 | -- |
| TARDIO JASON Chief Operating Officer | Stock Award(Grant) | Feb 22, 2024 | 28,125 |
| WILLIAMS DOUGLAS E Director | Purchase | Aug 14, 2018 | 5,000 |
Related Tickers
KZIA Kazia Therapeutics Limited
0.3890
-1.52%
UNCY Unicycive Therapeutics, Inc.
1.0400
-2.80%
RNA Avidity Biosciences, Inc.
25.09
-0.20%
INZY Inozyme Pharma, Inc.
4.4000
0.00%
BCDA BioCardia, Inc.
0.3795
+0.93%
IKNA Ikena Oncology, Inc.
1.2900
-4.44%
HOWL Werewolf Therapeutics, Inc.
6.39
-0.78%
KZR Kezar Life Sciences, Inc.
0.8014
-2.98%
XENE Xenon Pharmaceuticals Inc.
39.50
-3.87%
CYCN Cyclerion Therapeutics, Inc.
2.7700
0.00%